SEC Form D · Amendment · filed November 22, 2022
Enlaza Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
David R. Phaup · Edwardsville, ILDirectorTheodore Woo · Miami Beach, FLExecJay Lichter · La Jolla, CADirectorEric C. Harweger · Ames, IADirectorGerard M. Hayden, Jr · Nashville, TNExecChristopher Rand · Nashville, TNDirectorSergio Duron · La Jolla, CAExec · DirectorBrian M. Laden · Nashville, TNDirectorSanford Madigan · La Jolla, CAExecJames N. Topper · La Jolla, CADirectorShelley Chu · La Jolla, CADirectorMark S. Rosen · Morristown, NJDirectorMike D. Christensen · Edwardsville, ILDirectorMarcos Milla · La Jolla, CADirectorTyler M. Whitmore · Nashville, TNDirectorByron M. Smith · Nashville, TNExecMarc Chalfin · Miami Beach, FLExecTighe Reardon · La Jolla, CAExecRegan Bozman · San Francisco, CAExec · DirectorBruce E. Schneider · Venedy, ILDirectorMarc Chalfin · Miami Beach, FLExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗